These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22652506)
1. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment. Nolan JM; Akkali MC; Loughman J; Howard AN; Beatty S Exp Eye Res; 2012 Aug; 101():9-15. PubMed ID: 22652506 [TBL] [Abstract][Full Text] [Related]
2. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study. Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901 [TBL] [Abstract][Full Text] [Related]
3. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation. Stringham JM; Stringham NT Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932 [TBL] [Abstract][Full Text] [Related]
4. Spatial profile of macular pigment and its relationship to foveal architecture. Nolan JM; Stringham JM; Beatty S; Snodderly DM Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846 [TBL] [Abstract][Full Text] [Related]
5. Supplementation with all three macular carotenoids: response, stability, and safety. Connolly EE; Beatty S; Loughman J; Howard AN; Louw MS; Nolan JM Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9207-17. PubMed ID: 21979997 [TBL] [Abstract][Full Text] [Related]
6. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration. Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124 [TBL] [Abstract][Full Text] [Related]
7. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery. Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740 [TBL] [Abstract][Full Text] [Related]
8. Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials. Akuffo KO; Beatty S; Stack J; Dennison J; O'Regan S; Meagher KA; Peto T; Nolan J Ophthalmic Epidemiol; 2014 Apr; 21(2):111-23. PubMed ID: 24621122 [TBL] [Abstract][Full Text] [Related]
10. A central dip in the macular pigment spatial profile is associated with age and smoking. Kirby ML; Beatty S; Loane E; Akkali MC; Connolly EE; Stack J; Nolan JM Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6722-8. PubMed ID: 20592234 [TBL] [Abstract][Full Text] [Related]
11. Supplemental Retinal Carotenoids Enhance Memory in Healthy Individuals with Low Levels of Macular Pigment in A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Power R; Coen RF; Beatty S; Mulcahy R; Moran R; Stack J; Howard AN; Nolan JM J Alzheimers Dis; 2018; 61(3):947-961. PubMed ID: 29332050 [TBL] [Abstract][Full Text] [Related]
12. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793 [TBL] [Abstract][Full Text] [Related]
13. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Nolan JM; Stack J; O'connell E; Beatty S Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452 [TBL] [Abstract][Full Text] [Related]
14. Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration. Thurnham DI; Nolan JM; Howard AN; Beatty S Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1231-43. PubMed ID: 25311651 [TBL] [Abstract][Full Text] [Related]
15. Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration. Akuffo KO; Nolan JM; Howard AN; Moran R; Stack J; Klein R; Klein BE; Meuer SM; Sabour-Pickett S; Thurnham DI; Beatty S Eye (Lond); 2015 Jul; 29(7):902-12. PubMed ID: 25976647 [TBL] [Abstract][Full Text] [Related]
16. Central serous chorioretinopathy produces macular pigment profile changes. Putnam CM; Kinerk WT; Bassi CJ Optom Vis Sci; 2013 Jul; 90(7):e206-12. PubMed ID: 23770658 [TBL] [Abstract][Full Text] [Related]
17. Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. Sabour-Pickett S; Beatty S; Connolly E; Loughman J; Stack J; Howard A; Klein R; Klein BE; Meuer SM; Myers CE; Akuffo KO; Nolan JM Retina; 2014 Sep; 34(9):1757-66. PubMed ID: 24887490 [TBL] [Abstract][Full Text] [Related]
18. Macular telangiectasia: patterns of distribution of macular pigment and response to supplementation. Zeimer MB; Krömer I; Spital G; Lommatzsch A; Pauleikhoff D Retina; 2010 Sep; 30(8):1282-93. PubMed ID: 20671587 [TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973. Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699 [TBL] [Abstract][Full Text] [Related]
20. Profiles of macular pigment optical density and their changes following supplemental lutein and zeaxanthin: new results from the LUNA study. Zeimer M; Dietzel M; Hense HW; Heimes B; Austermann U; Pauleikhoff D Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4852-9. PubMed ID: 22743321 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]